Your browser is no longer supported. Please, upgrade your browser.
DPLO Diplomat Pharmacy, Inc. monthly Stock Chart
DPLO [NYSE]
Diplomat Pharmacy, Inc.
Index- P/E115.44 EPS (ttm)0.18 Insider Own0.20% Shs Outstand69.11M Perf Week-0.76%
Market Cap1.44B Forward P/E26.57 EPS next Y0.78 Insider Trans0.00% Shs Float48.17M Perf Month3.74%
Income12.30M PEG6.82 EPS next Q0.15 Inst Own71.40% Short Float14.66% Perf Quarter33.55%
Sales4.53B P/S0.32 EPS this Y1.30% Inst Trans1.17% Short Ratio12.33 Perf Half Y35.20%
Book/sh9.41 P/B2.21 EPS next Y4.69% ROA1.10% Target Price17.98 Perf Year-26.83%
Cash/sh0.11 P/C184.12 EPS next 5Y16.93% ROE2.00% 52W Range12.25 - 29.36 Perf YTD64.92%
Dividend- P/FCF30.04 EPS past 5Y18.00% ROI4.70% 52W High-28.58% Beta-
Dividend %- Quick Ratio0.90 Sales past 5Y41.70% Gross Margin7.30% 52W Low71.18% ATR0.69
Employees1737 Current Ratio1.40 Sales Q/Q3.50% Oper. Margin0.50% RSI (14)59.35 Volatility3.46% 3.00%
OptionableYes Debt/Eq0.21 EPS Q/Q-58.00% Profit Margin0.30% Rel Volume0.37 Prev Close20.78
ShortableYes LT Debt/Eq0.19 EarningsNov 01 AMC Payout0.00% Avg Volume572.87K Price20.97
Recom2.60 SMA200.29% SMA5011.62% SMA20028.34% Volume153,672 Change0.91%
Oct-05-17Reiterated Needham Buy $19.75 → $23.75
Jul-21-17Initiated Needham Buy $19.75
May-16-17Reiterated Mizuho Neutral $17 → $19
Nov-23-16Downgrade Credit Suisse Neutral → Underperform
Nov-03-16Reiterated Mizuho Neutral $39 → $17
Nov-03-16Downgrade Leerink Partners Outperform → Mkt Perform
Nov-03-16Downgrade Avondale Mkt Outperform → Mkt Perform
Aug-10-16Reiterated Mizuho Neutral $33 → $39
Aug-10-16Reiterated Leerink Partners Outperform $36 → $38
Jun-07-16Resumed BofA/Merrill Neutral
May-11-16Reiterated Mizuho Neutral $30 → $33
Apr-19-16Initiated Avondale Mkt Outperform $38
Mar-16-16Initiated Credit Suisse Neutral
Mar-01-16Downgrade Mizuho Buy → Neutral $30
Oct-21-15Reiterated Mizuho Buy $53 → $44
Oct-14-15Upgrade BofA/Merrill Underperform → Neutral
Oct-02-15Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-04-15Reiterated Leerink Partners Outperform $40 → $55
Jul-16-15Initiated BofA/Merrill Underperform
Jul-09-15Resumed Morgan Stanley Overweight $41 → $56
Oct-16-17 01:30PM  Diplomat to Release Third Quarter 2017 Operating Results and Host Conference Call on Monday, November 6, 2017 PR Newswire
09:51AM  ETFs with exposure to Diplomat Pharmacy, Inc. : October 16, 2017 Capital Cube
Oct-10-17 08:00AM  Diplomat Selected to Dispense VERZENIO for Breast Cancer PR Newswire
Oct-04-17 04:15PM  Diplomat Among Best and Brightest in Wellness® for 5th Straight Year PR Newswire
Oct-02-17 04:15PM  Diplomat Acquires 8th Day Software, Names New CIO PR Newswire
10:48AM  ETFs with exposure to Diplomat Pharmacy, Inc. : October 2, 2017 Capital Cube
Sep-29-17 08:56AM  Diplomat Pharmacy, Inc. :DPLO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017 Capital Cube
Sep-27-17 03:00AM  Diplomat Pharmacy Joins Elite Club Of Stocks With RS Ratings Over 90 Investor's Business Daily
Sep-21-17 03:00AM  Diplomat Pharmacy Hits 80-Plus Relative Strength Rating Benchmark Investor's Business Daily
Sep-11-17 06:04PM  Diplomat Acquires Focus Rx PR Newswire
Aug-29-17 04:30PM  ThriveRx Contributes to Resource Paper on Nutrition Support at School PR Newswire
Aug-23-17 04:30PM  Diplomat Receives Graphic Design USA Awards for 4th Consecutive Year PR Newswire
Aug-22-17 10:10AM  Diplomat to Participate in Upcoming Investor Conferences PR Newswire
Aug-21-17 06:07PM  Diplomat Pharmacy, Inc. Value Analysis (NYSE:DPLO) : August 21, 2017 Capital Cube
Aug-17-17 04:30PM  Diplomat Dispensing MAVYRET to Treat Chronic Hepatitis C PR Newswire
11:39AM  Zacks.com featured highlights: Big Lots, Camping World Holdings, Town Sports International Holdings, Global Brass and Copper Holdings and Diplomat Pharmacy Zacks
Aug-15-17 04:30PM  Diplomat Dispensing Opioid-Overdose Antidote Naloxone PR Newswire
Aug-14-17 08:00AM  EnvoyHealth Partners With Health Care Management Company PharMedQuest PR Newswire
Aug-12-17 01:30AM  Edited Transcript of DPLO earnings conference call or presentation 7-Aug-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-11-17 10:50PM  DIPLOMAT PHARMACY INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Diplomat Pharmacy, Inc. - DPLO Business Wire
Aug-10-17 04:06PM  Diplomat Pharmacy Inc Makes Up for Lost Contracts Motley Fool
Aug-09-17 08:21AM  Diplomat Pharmacy, Inc. breached its 50 day moving average in a Bullish Manner : DPLO-US : August 9, 2017 Capital Cube
Aug-07-17 11:56PM  Diplomat Pharmaceuticals posts 2Q profit Associated Press
04:18PM  Diplomat Announces 2nd Quarter Financial Results PR Newswire
04:15PM  Diplomat Announces A New President PR Newswire
12:00PM  Investor Network: Diplomat Pharmacy, Inc. to Host Earnings Call ACCESSWIRE
Aug-04-17 10:50PM  DIPLOMAT PHARMACY INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Diplomat Pharmacy, Inc. - DPLO PR Newswire
Aug-03-17 08:00AM  Diplomat Named Exclusive Distributor of NITYR PR Newswire
Jul-31-17 04:30PM  Diplomat Named Among Fastest-Growing Companies in Southeast Michigan PR Newswire
Jul-27-17 04:30PM  Diplomat Partners With Labor Value Rx to Support Specialty Members PR Newswire
Jul-26-17 08:05AM  Diplomat Now Dispensing VOSEVI to Treat Chronic Hepatitis C Virus PR Newswire
Jul-24-17 03:27PM  ETFs with exposure to Diplomat Pharmacy, Inc. : July 24, 2017 Capital Cube
11:00AM  Diplomat to Release Second Quarter 2017 Operating Results and Host Conference Call on Monday, August 7, 2017 PR Newswire
08:07AM  DIPLOMAT PHARMACY (DPLO) SHAREHOLDER ALERT Andrews & Springer LLC is Investigating Diplomat Pharmacy, Inc. for Potential Securities Violations and Breaches of Fiduciary Duty Business Wire
Jul-20-17 04:30PM  NERLYNX (neratinib) tablets for HER2+ Breast Cancer in the Extended Adjuvant Setting PR Newswire
Jul-18-17 06:35PM  Fool Mailbag: When Should You Double Down on a Falling Stock? Motley Fool
Jul-14-17 02:00PM  ETFs with exposure to Diplomat Pharmacy, Inc. : July 14, 2017 Capital Cube
Jul-06-17 08:05AM  ThriveRx Celebrates 10th Anniversary, Launches New Platforms PR Newswire
Jun-28-17 03:24PM  Diplomat Pharmacy, Inc. Value Analysis (NYSE:DPLO) : June 28, 2017 Capital Cube
02:44PM  ETFs with exposure to Diplomat Pharmacy, Inc. : June 28, 2017 Capital Cube
Jun-27-17 08:53AM  Diplomat Pharmacy, Inc. breached its 50 day moving average in a Bearish Manner : DPLO-US : June 27, 2017 Capital Cube -7.33%
Jun-26-17 06:30PM  Here's Why Diplomat Pharmacy Inc. Shares Are Down as Much as 13% Motley Fool -10.17%
Jun-16-17 03:40PM  ETFs with exposure to Diplomat Pharmacy, Inc. : June 16, 2017 Capital Cube
Jun-15-17 04:23PM  3 Healthcare Stocks for Ambitious Investors Motley Fool
Jun-08-17 04:30PM  Jeff Park Elected to Diplomat Board of Directors PR Newswire
Jun-06-17 04:30PM  Diplomat Specialty Infusion Group Now Providing Parenteral Nutrition Therapies in Iowa PR Newswire
Jun-05-17 04:30PM  Diplomat Specialty Infusion Group Cincinnati Named Top Workplaces PR Newswire
Jun-02-17 02:02PM  ETFs with exposure to Diplomat Pharmacy, Inc. : June 2, 2017 Capital Cube
May-25-17 04:30PM  Diplomat to Dispense KEVZARA® for Treatment of Rheumatoid Arthritis PR Newswire
May-24-17 04:30PM  Diplomat Recognized as Economic Bright Spot by Corp! Magazine PR Newswire
May-23-17 08:05AM  Diplomat Partners With Medication Adherence Company SMRxT PR Newswire
May-22-17 03:00PM  Diplomat to Host Analyst and Investor Day on June 27, 2017 PR Newswire
01:34PM  ETFs with exposure to Diplomat Pharmacy, Inc. : May 22, 2017 Capital Cube
May-19-17 10:12AM  Diplomat Pharmacy, Inc. :DPLO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017 Capital Cube
May-18-17 04:30PM  Diplomat Now Dispensing RYDAPT® (Midostaurin) for Acute Myeloid Leukemia PR Newswire
May-13-17 01:15PM  Edited Transcript of DPLO earnings conference call or presentation 8-May-17 9:00pm GMT Thomson Reuters StreetEvents
May-09-17 08:20PM  Edited Transcript of DPLO earnings conference call or presentation 8-May-17 9:00pm GMT Thomson Reuters StreetEvents +9.25%
03:29PM  Here's Why Diplomat Pharmacy Inc. Is Rising Today Motley Fool
May-08-17 07:28PM  Diplomat Pharmacy, Inc. Q1 Earnings Suffer From Hepatitis C Headwinds and Higher DIR Fees Motley Fool
04:59PM  Diplomat Pharmaceuticals posts 1Q profit Associated Press
04:20PM  Diplomat Announces 1st Quarter Financial Results PR Newswire
04:10PM  Diplomat Acquires WRB Communications PR Newswire
12:19PM  5 Earnings Short-Squeeze Plays: Snap, NVIDIA & More TheStreet.com
May-03-17 02:00PM  Diplomat to Participate in Bank of America Merrill Lynch 2017 Healthcare Conference PR Newswire
Apr-19-17 05:08PM  Diplomat Will Dispense ZEJULA to Treat Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PR Newswire
02:59PM  Diplomat Pharmacy, Inc. Value Analysis (NYSE:DPLO) : April 19, 2017 Capital Cube
Apr-18-17 08:30AM  Diplomat Pharmacy, Inc. breached its 50 day moving average in a Bullish Manner : DPLO-US : April 18, 2017 Capital Cube
Apr-17-17 11:00AM  Diplomat to Release First Quarter 2017 Operating Results and Host Conference Call on Monday, May 8, 2017 PR Newswire
Apr-13-17 05:10PM  Diplomat Promotes Executive Jennifer Cretu PR Newswire
Apr-12-17 04:30PM  Diplomat Partners With Corizon Health to Dispense Specialty Drugs PR Newswire
Apr-11-17 08:00AM  Diplomat Appoints New Chief Financial Officer PR Newswire
Apr-06-17 04:30PM  Dr. Regina Benjamin Appointed to Diplomat's Board of Directors PR Newswire
Apr-05-17 04:38PM  ETFs with exposure to Diplomat Pharmacy, Inc. : April 5, 2017 Capital Cube
08:22AM  Diplomat Pharmacy, Inc. breached its 50 day moving average in a Bearish Manner : DPLO-US : April 5, 2017 Capital Cube
Apr-02-17 02:01PM  3 Top Specialty Pharma Stocks to Buy in 2017 Motley Fool
Mar-29-17 04:30PM  Diplomat Will Dispense OCREVUS to Treat Multiple Sclerosis PR Newswire
Mar-28-17 04:33PM  Diplomat to Dispense DUPIXENT® to Treat Atopic Dermatitis PR Newswire
Mar-16-17 04:30PM  Diplomat to Dispense KISQALI® for Metastatic Breast Cancer PR Newswire
Mar-14-17 01:04PM  DIPLOMAT PHARMACY, INC. Financials
Mar-08-17 05:22PM  DIPLOMAT PHARMACY, INC. Files SEC form 10-K, Annual Report
Mar-06-17 08:00AM  Diplomat to Dispense XERMELO for Patients With Carcinoid Syndrome Diarrhea PR Newswire
Mar-03-17 12:24PM  Diplomat Pharmacy, Inc. :DPLO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017 Capital Cube
Mar-02-17 02:04PM  Diplomat Pharmacy, Inc. :DPLO-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017
08:00AM  Diplomat Dispensing REVLIMID® for Multiple Myeloma Maintenance Therapy Following Autologous Hematopoietic Stem Cell Transplant (Auto-HSCT) PR Newswire
Mar-01-17 04:00PM  Diplomat Pharmacy's Shares Are Soaring Today -- But Why? Motley Fool +10.11%
03:55AM  Edited Transcript of DPLO earnings conference call or presentation 28-Feb-17 10:00pm GMT
Feb-28-17 07:02PM  Diplomat Pharmacy, Inc. Q4 Earnings Hurt by Hep-C Headwinds at Motley Fool -5.97%
06:21PM  DIPLOMAT PHARMACY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
05:03PM  Diplomat Pharmaceuticals posts 4Q loss
04:15PM  Diplomat Announces 4th Quarter and 2016 Year End Financial Results; Provides Initial 2017 Guidance PR Newswire
07:07AM  Q4 2016 Diplomat Pharmacy Inc Earnings Release - After Market Close
Feb-27-17 01:14PM  5 Earnings Short-Squeeze Plays to Boost Your Returns
Feb-21-17 05:47PM  Meridian Growth Fund 4th Quarter Commentary
02:00PM  Diplomat to Participate in Upcoming Investor Conferences PR Newswire
09:30AM  Zacks.com featured highlights: American Axle & Manufacturing Holdings, AmerisourceBergen, Basic Energy Services, Diplomat Pharmacy and California Resources
Feb-17-17 07:57AM  5 Stocks in Favor With Brokers Right Now
Feb-14-17 04:30PM  Diplomat Enhances Corporate Governance With Appointment of Ben Wolin to Newly-Created Role of Lead Director PR Newswire
Feb-07-17 02:00PM  Diplomat to Release Fourth Quarter and Full Year 2016 Operating Results and Host Conference Call on Tuesday, February 28, 2017 PR Newswire
Feb-06-17 12:00PM  Bullish and Bearish Reversals for the Week
Feb-03-17 08:40AM  Diplomat Pharmacy (DPLO) Catches Eye: Stock Jumps 9.4%
Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company stocks, dispenses, and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. It also provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training/consulting, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems. The company's primary focus is on medication management programs for individuals with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy, and various other serious or long-term conditions. Diplomat Pharmacy, Inc. has 19 pharmacy locations in Arizona, California, Connecticut, Florida, Illinois, Iowa, Maryland, Massachusetts, Michigan, Minnesota, North Carolina, Ohio, Pennsylvania, and Texas. The company was founded in 1975 and is headquartered in Flint, Michigan.